Selskabets formål er udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -866 t. | -893 t. | 1.5 mio. | -939 t. | 1 | |
CVR: 44445832
Previous names: Selskabet af 21. november 2023 ApS
Compared to 1.012 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Claus Elsborg Olesen joined the board
Sten Verland joined the board
Claus Elsborg Olesen left the board
Claus Elsborg Olesen joined the board
Martin Roelsgaard Jakobsen joined the board
Companies in the same industry and area
companydata.dk